home / stock / cnsp / cnsp short
Short Information | CNS Pharmaceuticals Inc. (NYSE:CNSP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 150,102 |
Total Actual Volume | 1,118,119 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 7,505 |
Average Short Percentage | 11.89% |
Is there a CNSP Short Squeeze or Breakout about to happen?
See the CNSP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $4.15 | $4.11 | $4.2986 | $4.10 | 44,730 | 13,616 | 30.44% |
02-11-2020 | $4.29 | $4.10 | $4.30 | $4.08 | 34,604 | 3,056 | 8.83% |
02-10-2020 | $4.17 | $4.06 | $4.20 | $4.06 | 51,642 | 7,760 | 15.03% |
02-07-2020 | $4.33 | $4.27 | $4.45 | $4.2009 | 46,271 | 529 | 1.14% |
02-06-2020 | $4.44 | $4.37 | $4.563 | $4.31 | 28,828 | 781 | 2.71% |
02-05-2020 | $4.71 | $4.44 | $4.71 | $4.37 | 42,014 | 2,371 | 5.64% |
02-04-2020 | $4.35 | $4.60 | $4.75 | $4.35 | 111,600 | 22,433 | 20.1% |
02-03-2020 | $4.32 | $4.36 | $4.40 | $4.28 | 33,278 | 2,375 | 7.14% |
01-31-2020 | $4.37 | $4.31 | $4.37 | $4.252 | 36,932 | 2,107 | 5.71% |
01-30-2020 | $4.18 | $4.35 | $4.3599 | $4.12 | 107,353 | 29,312 | 27.3% |
01-29-2020 | $4.27 | $4.12 | $4.30 | $4.09 | 43,414 | 3,991 | 9.19% |
01-28-2020 | $4.30 | $4.23 | $4.38 | $4.16 | 66,638 | 7,127 | 10.7% |
01-27-2020 | $4.39 | $4.32 | $4.40 | $4.24 | 70,676 | 2,968 | 4.2% |
01-24-2020 | $4.46 | $4.40 | $4.50 | $4.39 | 33,931 | 4,487 | 13.22% |
01-23-2020 | $4.45 | $4.45 | $4.50 | $4.3927 | 71,859 | 14,414 | 20.06% |
01-22-2020 | $4.46 | $4.3936 | $4.4676 | $4.33 | 54,803 | 6,436 | 11.74% |
01-21-2020 | $4.38 | $4.48 | $4.49 | $4.3501 | 63,665 | 7,362 | 11.56% |
01-17-2020 | $4.49 | $4.33 | $4.49 | $4.25 | 46,317 | 4,732 | 10.22% |
01-16-2020 | $4.40 | $4.46 | $4.55 | $4.39 | 60,069 | 10,230 | 17.03% |
01-15-2020 | $4.40 | $4.37 | $4.4634 | $4.22 | 69,495 | 4,015 | 5.78% |
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
Scientists at Purdue University are trying to develop a new treatment for glioblastoma tumors. Glioblastoma is a type of cancer that originates in the spinal cord and/or brain. This cancer is fatal, with a median time of survival of 14 months. Conventional treatments for other cancers, includ...
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced that its Chief Executive Officer John Climaco will present at the LSX World Congress 20...
Presentation on Monday, April 29 th at 4:15 PM (GMT+1) HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the ...